One day we will hopefully be seeing OCC management themselves at these two massively important bio-tech investment conferences. But for now I'd happily take a little second hand exposure from Henry Schein/BioHorizons.
Every US bio-tech analyst will be at both events.
Media thread, page-523
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.5¢ |
Change
-0.005(1.25%) |
Mkt cap ! $82.68M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 40.0¢ | 39.0¢ | $58.05K | 146.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 281 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 193037 | 5 |
View Market Depth
| Last trade - 14.48pm 12/07/2024 (20 minute delay) ? |
| OCC (ASX) Chart |